Startups
Genesis BioCapital is a venture capital firm focused on creating and scaling biopharmaceutical companies pursuing transformative therapies that address significant unmet medical needs. It has a highly experienced multidisciplinary team of biopharma executives and fund operators. Genesis runs an innovative dual strategy incorporating company formation and growth investing.
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 10, 2025 | 32 Biosciences Surpasses Financing Target, Accelerates Toward Series A and FDA Milestones | Microbiome-focused company receives $6 million in funding to advance gut microbiome platform technologies NORTH CHICAGO, Ill.–(BUSINESS WIRE)–June 10, 2025– 32 Biosciences, a leader in the field of gut microbiome medicine, today announced i... |
Reviews 0
FAQ about Genesis BioCapital
What has the press written about Genesis BioCapital?
Parsers VC has collected 2 articles mentioning Genesis BioCapital, among them “32 Biosciences Surpasses Financing Target, Accelerates Toward Series A and FDA Milestones” (Jun 10, 2025).
Is Genesis BioCapital still active?
Yes, Genesis BioCapital is active; its latest activity on Parsers VC dates from Jun 12, 2025.